Suchergebnisse - "Lalwani, Sanjay"

PubPharm (120)

1

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) : 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults

enthalten in: Human vaccines & immunotherapeutics | 2024

von Kulkarni, P. | Padmapriyadarsini, C. | Vekemans, J. | +29

2

Evaluation of Pertussis Disease in Young Infants in India : A Hospital-Based Multicentric Observational Study

enthalten in: Indian journal of pediatrics | 2024

von Singh, V. | S, B. | Lalwani, S. | +8

3

A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL®) in infants

enthalten in: NPJ vaccines | 2024

von Sharma, H. | Parekh, S. | Pujari, P. | +26

4

Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP) : Recommended Immunization Schedule (2023) and Update on Immunization for Children Aged 0 Through 18 Years

enthalten in: Indian pediatrics | 2024

von Rao M, I. | Kasi, S. | Dhir, S. | +12

5

Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): Recommended Immunization Schedule (2023) and Update on Immunization for Children Aged 0 Through 18 Years

enthalten in: Indian Pediatrics | 2024

von Rao, M. | Kasi, S. | Dhir, S. | +12

6

A Phase 2/3 observer-blind, randomized, controlled study to determine the safety and immunogenicity of SARS-CoV-2 recombinant spike protein vaccine in Indian children and adolescents aged 2 to 17 years

enthalten in: bioRxiv.org | 2023

von Gunale, B. | Kapse, D. | Kar, S. | +23

7

Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India : a randomised, active-controlled, multicentre, phase 2/3 trial

enthalten in: The Lancet. Oncology | 2023

von Sharma, H. | Parekh, S. | Pujari, P. | +24

8

A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults

enthalten in: Scientific reports | 2023

von Kulkarni, P. | Gunale, B. | Kohli, S. | +41

9

Longitudinal profile of high-sensitivity C-reactive protein in women with pre-eclampsia

enthalten in: American journal of reproductive immunology (New York, N.Y. : 1989) | 2023

von Dangat, K. | Wadhwani, N. | Randhir, K. | +5

10

Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India : A Phase 2-3 Randomized Clinical Trial

enthalten in: JAMA pediatrics | 2023

von Gunale, B. | Kapse, D. | Kar, S. | +50

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]